Ocuphire shares investor presentation; no material new details available

Opus Genetics, Inc.

Company furnished investor presentation under Regulation FD for March 2024 meetings.
Exhibit 99.1 content is incomplete; no specific financial or operational updates provided.
Presentation intended for routine investor outreach; no material changes disclosed.

item 7.01 item 9.01

Opus Genetics, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-24-015624

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.